Detalhe da pesquisa
1.
Risk factors during the early postpartum period for type 2 diabetes mellitus in women with gestational diabetes.
Endocr J
; 67(4): 427-437, 2020 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969529
2.
Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.
Cardiovasc Diabetol
; 16(1): 149, 2017 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29132354
3.
Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.
Cardiovasc Diabetol
; 16(1): 8, 2017 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28086872
4.
Comparison of liraglutide plus basal insulin and basal-bolus insulin therapy (BBIT) for glycemic control, body weight stability, and treatment satisfaction in patients treated using BBIT for type 2 diabetes without severe insulin deficiency: A randomized prospective pilot study.
Diabetes Res Clin Pract
; 140: 339-346, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29588170
5.
Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Early-Phase Insulin Secretion in Drug-Naïve Patients with Type 2 Diabetes.
Drugs R D
; 15(3): 245-51, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26224337
6.
Present status of clinical care for postpartum patients with hypertensive disorders of pregnancy in Japan: findings from a nationwide questionnaire survey.
Hypertens Pregnancy
; 34(2): 209-20, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25774557